METASTATIC PROSTATE CANCER
Clinical trials for METASTATIC PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC PROSTATE CANCER trials appear
Sign up with your email to follow new studies for METASTATIC PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Radical surgery trial aims to extend control of spreading prostate cancer
Disease control Not yet recruitingThis study is for men whose prostate cancer has already spread to other parts of the body when first diagnosed. It tests whether adding surgery to remove the prostate (or radiation) to standard drug therapy helps control the cancer for a longer time without it getting worse, comp…
Matched conditions: METASTATIC PROSTATE CANCER
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Apr 04, 2026 02:20 UTC
-
Diabetes drug shows promise in fighting advanced prostate cancer
Disease control Not yet recruitingThis study is testing if adding a common diabetes drug, dapagliflozin, to standard hormone therapy helps control advanced prostate cancer that has spread and stopped responding to standard hormone treatments. It will involve 60 men whose cancer has spread and who are starting a s…
Matched conditions: METASTATIC PROSTATE CANCER
Phase: PHASE2 • Sponsor: Yung NA • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New hope for men with advanced prostate cancer: radioactive drug trial seeks to control disease after other treatments fail
Disease control Not yet recruitingThis trial is testing a new radioactive drug called Actinium rhPSMA-10.1 for men with advanced prostate cancer that has spread and stopped responding to standard hormone treatments. The drug is designed to find and destroy prostate cancer cells throughout the body using targeted …
Matched conditions: METASTATIC PROSTATE CANCER
Phase: PHASE1, PHASE2 • Sponsor: University College, London • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
New Two-Pronged attack on advanced prostate cancer in the liver
Disease control Not yet recruitingThis early-stage study is testing the safety of combining two treatments for advanced prostate cancer that has spread to the liver. It will give a radioactive drug that targets prostate cancer cells, along with a separate treatment focused directly on the liver tumors. The goal i…
Matched conditions: METASTATIC PROSTATE CANCER
Phase: PHASE1 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC
-
Could a tiny pill fight cancer treatment exhaustion?
Symptom relief Not yet recruitingThis study aims to see if a very small daily dose of naltrexone (LDN) can safely reduce severe tiredness in men with prostate cancer who are receiving hormone therapy. Researchers will enroll 60 men who are experiencing significant fatigue from their treatment. The main goal is t…
Matched conditions: METASTATIC PROSTATE CANCER
Phase: PHASE2 • Sponsor: University of Arkansas • Aim: Symptom relief
Last updated Apr 03, 2026 14:43 UTC
-
AI-Powered registry tracks advanced prostate cancer treatment in real life
Knowledge-focused Not yet recruitingThis study aims to understand how a specific treatment for metastatic prostate cancer is used in real-world medical practice. It will observe about 750 patients who have already received the drug, collecting data on their treatment patterns, side effects, and health outcomes. The…
Matched conditions: METASTATIC PROSTATE CANCER
Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:11 UTC